Cooley advised New Enterprise Associates (NEA) on leading Trevi Therapeutics’ $50.5 million Series C financing round. The financing round included new investors Lundbeckfonden Ventures, Omega Funds,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
